1.HDAC1 Expression in Invasive Ductal Carcinoma of the Breast and Its Value as a Good Prognostic Factor.
Minseob EOM ; Sung Soo OH ; Sayamaa LKHAGVADORJ ; Airi HAN ; Kwang Hwa PARK
Korean Journal of Pathology 2012;46(4):311-317
BACKGROUND: Histone deacetylase 1 (HDAC1) is associated with the expression and function of estrogen receptors and the proliferation of tumor cells, and has been considered a very important factor in breast tumor progression and prognosis. Several studies have reported an association between HDAC1 expression and poorer prognosis in cancers including breast cancer, with a few exceptions. However, because of the dearth of studies on HDAC1 expression in breast cancer, its significance for breast cancer prognosis has not been well defined. Therefore, we examined HDAC1 expression in invasive ductal carcinoma (IDC), the most common breast cancer, and investigated its potential prognostic significance. METHODS: We used 203 IDC tissue samples. Immunohistochemical stains for HDAC1 and real-time polymerase chain reaction for HDAC1 mRNA were performed and the results were compared to generally well-established prognostic factors in breast cancer and patient survival rates. RESULTS: HDAC1 expression was significantly reduced in proportion to higher histologic grade, higher nuclear pleomorphism score, and higher mitotic counts, and with lower estrogen receptor expression. Furthermore, it was significantly associated with the survival rate. CONCLUSIONS: HDAC1 expression is a good prognostic indicator in IDC.
Breast
;
Breast Neoplasms
;
Carcinoma, Ductal
;
Carcinoma, Ductal, Breast
;
Coloring Agents
;
Estrogens
;
Histone Deacetylase 1
;
Humans
;
Prognosis
;
Real-Time Polymerase Chain Reaction
;
Receptors, Estrogen
;
RNA, Messenger
2.ROS1 Expression in Invasive Ductal Carcinoma of the Breast Related to Proliferation Activity.
Minseob EOM ; Sayamaa LKHAGVADORJ ; Sung Soo OH ; Airi HAN ; Kwang Hwa PARK
Yonsei Medical Journal 2013;54(3):650-657
PURPOSE: ROS1 is an oncogene, expressed primarily in glioblastomas of the brain that has been hypothesized to mediate the effects of early stage tumor progression. In addition, it was reported that ROS1 expression was observed in diverse cancer tissue or cell lines and ROS1 is associated with the development of several tumors. However, ROS1 expression has not been studied in breast cancer to date. Therefore, we investigated ROS1 expression at the protein and gene level to compare expression patterns and to verify the association with prognostic factors in invasive ductal carcinoma (IDC) of the breast. MATERIALS AND METHODS: Tissue samples from 203 patients were used. Forty-six cases were available for fresh tissue. We performed immunohistochemical staining and real-time polymerase chain reaction (PCR). RESULTS: ROS1 expression was significantly lower in proportion to higher histologic grade, higher mitotic counts, lower estrogen receptor expression, and a higher Ki-67 proliferation index, although ROS1 expression was not significantly associated with the survival rate. The result of real-time PCR revealed similar trends, however not statistically significant. CONCLUSION: Higher ROS1 expression may be associated with favorable prognostic factors of IDC and its expression in IDC is related to the proliferation of tumor cells.
Adult
;
Aged
;
Aged, 80 and over
;
Breast Neoplasms/*metabolism/pathology
;
Carcinoma, Ductal, Breast/*metabolism/pathology
;
Cell Proliferation
;
Female
;
Humans
;
Immunohistochemistry
;
Middle Aged
;
Neoplasm Grading
;
Prognosis
;
Protein-Tyrosine Kinases/genetics/*metabolism
;
Proto-Oncogene Proteins/genetics/*metabolism
;
Survival Analysis
3.Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
Sayamaa LKHAGVADORJ ; Ji Hee KIM ; Sung Soo OH ; Mi Ra LEE ; Jae Hung JUNG ; Hyun Chul CHUNG ; Seung Kuy CHA ; Minseob EOM
Journal of Korean Medical Science 2016;31(6):879-885
Store-operated calcium (Ca2+) entry (SOCE) is the principal Ca2+ entry route in non-excitable cells, including cancer cells. We previously demonstrated that Orai1 and STIM1, the molecular components of SOCE, are involved in tumorigenesis of clear cell renal cell carcinoma (CCRCC). However, a clinical relevance of Orai1 and STIM1 expression in CCRCC has been ill-defined. Here, we investigated the expression of Orai1 and STIM1 in CCRCC, and compared their expression with clinico-pathological parameters of CCRCC and the patients' outcome. Immunohistochemical staining for Orai1 and STIM1 was performed on 126 formalin fixed paraffin embedded tissue of CCRCC and western blot analysis for Orai1 was performed on the available fresh tissue. The results were compared with generally well-established clinicopathologic prognostic factors in CCRCC and patient survival. Membrane protein Orai1 is expressed in the nuclei in CCRCC, whereas STIM1 shows the cytosolic expression pattern in immunohistochemical staining. Orai1 expression level is inversely correlated with CCRCC tumor grade, whereas STIM1 expression level is not associated with tumor grade. The higher Orai1 expression is significantly associated with lower Fuhrman nuclear grade, pathologic T stage, and TNM stage and with favorable prognosis. The expression level of STIM1 is not correlated with CCRCC grade and clinical outcomes. Orai1 expression in CCRCC is associated with tumor progression and with favorable prognostic factors. These results suggest that Orai1 is an attractive prognostic marker and therapeutic target for CCRCC.
Adolescent
;
Adult
;
Aged
;
Blotting, Western
;
Carcinoma, Renal Cell/*diagnosis/metabolism/*pathology
;
Female
;
*Gene Expression Regulation, Neoplastic
;
Humans
;
Immunohistochemistry
;
Kidney Neoplasms/metabolism/*pathology
;
Male
;
Middle Aged
;
Neoplasm Proteins/genetics/metabolism
;
ORAI1 Protein/genetics/*metabolism
;
Prognosis
;
Retrospective Studies
;
Stromal Interaction Molecule 1/genetics/metabolism
;
Young Adult
4.Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis.
Sayamaa LKHAGVADORJ ; Sung Soo OH ; Mi Ra LEE ; Jae Hung JUNG ; Hyun Chul CHUNG ; Seung Kuy CHA ; Minseob EOM
Yonsei Medical Journal 2014;55(4):861-870
PURPOSE: Both insulin and insulin-like growth factor (IGF)-1 signaling are key regulators of energy metabolism, cellular growth, proliferation, and survival. The IGF-1 receptor (IGF-1R) is overexpressed in most types of human cancers including renal cell carcinoma (RCC) with poor prognosis. Insulin receptor (IR) shares downstream effectors with IGF-1R; however, the expression and function of IR in the tumorigenesis of renal cancer remains elusive. Therefore, we examined the expression of IR and its prognostic significance in clear cell RCC (CCRCC). MATERIALS AND METHODS: Immunohistochemical staining for IR was performed on 126 formalin-fixed paraffin-embedded CCRCC tissue samples. Eight of these cases were utilized for western blot analysis. The results were compared with various clinico-pathologic parameters of CCRCC and patient survival. RESULTS: IR was expressed in the nuclei of CCRCC tumor cells in 109 cases (87.9%). Higher IR expression was significantly correlated with the presence of cystic change, lower Fuhrman nuclear grade, lower pathologic T stage, and lower TNM stage, although it wasn't significantly related to diabetes status and patient survival. Western blot analyses supported the results of the immunohistochemistry studies. CONCLUSION: IR expression in CCRCC may be associated with favorable prognostic factors.
Aged
;
Blotting, Western
;
Carcinoma, Renal Cell/*metabolism/*pathology
;
Female
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
;
Prognosis
;
Receptor, Insulin/*metabolism
5.Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis.
Sayamaa LKHAGVADORJ ; Sung Soo OH ; Mi Ra LEE ; Jae Hung JUNG ; Hyun Chul CHUNG ; Seung Kuy CHA ; Minseob EOM
Yonsei Medical Journal 2014;55(4):861-870
PURPOSE: Both insulin and insulin-like growth factor (IGF)-1 signaling are key regulators of energy metabolism, cellular growth, proliferation, and survival. The IGF-1 receptor (IGF-1R) is overexpressed in most types of human cancers including renal cell carcinoma (RCC) with poor prognosis. Insulin receptor (IR) shares downstream effectors with IGF-1R; however, the expression and function of IR in the tumorigenesis of renal cancer remains elusive. Therefore, we examined the expression of IR and its prognostic significance in clear cell RCC (CCRCC). MATERIALS AND METHODS: Immunohistochemical staining for IR was performed on 126 formalin-fixed paraffin-embedded CCRCC tissue samples. Eight of these cases were utilized for western blot analysis. The results were compared with various clinico-pathologic parameters of CCRCC and patient survival. RESULTS: IR was expressed in the nuclei of CCRCC tumor cells in 109 cases (87.9%). Higher IR expression was significantly correlated with the presence of cystic change, lower Fuhrman nuclear grade, lower pathologic T stage, and lower TNM stage, although it wasn't significantly related to diabetes status and patient survival. Western blot analyses supported the results of the immunohistochemistry studies. CONCLUSION: IR expression in CCRCC may be associated with favorable prognostic factors.
Aged
;
Blotting, Western
;
Carcinoma, Renal Cell/*metabolism/*pathology
;
Female
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
;
Prognosis
;
Receptor, Insulin/*metabolism
6.Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome.
Ji Hee KIM ; Kyu Hee HWANG ; Sayamaa LKHAGVADORJ ; Jae Hung JUNG ; Hyun Chul CHUNG ; Kyu Sang PARK ; In Deok KONG ; Minseob EOM ; Seung Kuy CHA
The Korean Journal of Physiology and Pharmacology 2016;20(3):297-304
Klotho functions as a tumor suppressor predominantly expressed in renal tubular cells, the origin of clear cell renal cell carcinoma (ccRCC). Altered expression and/or activity of growth factor receptor have been implicated in ccRCC development. Although Klotho suppresses a tumor progression through growth factor receptor signaling including insulin-like growth factor-1 receptor (IGF-1R), the role of Klotho acting on IGF-1R in ccRCC and its clinical relevance remains obscure. Here, we show that Klotho is favorable prognostic factor for ccRCC and exerts tumor suppressive role for ccRCC through inhibiting IGF-1R signaling. Our data shows the following key findings. First, in tumor tissues, the level of Klotho and IGF-1R expression are low or high, respectively, compared to that of adjacent non-neoplastic parenchyma. Second, the Klotho expression is clearly low in higher grade of ccRCC and is closely associated with clinical outcomes in tumor progression. Third, Klotho suppresses IGF-1-stimulated cell proliferation and migration by inhibiting PI3K/Akt pathway. These results provide compelling evidence supporting that Klotho acting on IGF-1R signaling functions as tumor suppressor in ccRCC and suggest that Klotho is a potential carcinostatis substance for ccRCC.
Carcinoma, Renal Cell*
;
Cell Proliferation
;
Prognosis
;
Receptor, IGF Type 1